XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 81,632,704 $ 61,750,809
Restricted cash 4,369,868 4,306,519
Prepayment and other current assets, net 6,834,769
Loan receivables 800,000 800,000
Total current assets 86,802,572 73,692,097
Non-current assets    
Non-marketable investment, net
Total non-current assets
Total assets 86,802,572 73,692,097
Current liabilities    
Accrued expenses and other payables 1,207,534 3,259,319
Advance from customers 4,369,868 4,306,519
Warrant liabilities 6,098,858 4,971,869
Tax payables 359,250 350,752
Total current liabilities 12,035,510 12,888,459
Total liabilities 12,035,510 12,888,459
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY    
Common stock (20,000,000 shares authorized; $0.05 par value; 4,080,380 shares issued and outstanding as of June 30, 2024; 1,399,675 shares issued and outstanding as of December 31, 2023) [1] 204,269 38,491
Additional paid-in capital 103,238,268 95,726,623
Accumulated deficit (28,675,475) (34,961,476)
Accumulated other comprehensive loss
Total shareholders’ equity 74,767,062 60,803,638
Total liabilities and shareholders’ equity $ 86,802,572 $ 73,692,097
[1] All shares and per share data have been retroactively restated to reflect reverse stock split effected on April 12, 2024 onwards